These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15469787)

  • 41. Effect of atorvastatin on endothelium-dependent vasodilation in patients with coronary artery disease.
    Vita JA; Gokce N; Duffy SJ; Kahn D; Tomasian D; Palmisano J; Thomas S; Holbrook M; Keaney JF
    Am J Cardiol; 2003 Apr; 91(7):857-60. PubMed ID: 12667571
    [No Abstract]   [Full Text] [Related]  

  • 42. Hemostatic effects of atorvastatin versus simvastatin.
    Kadikoylu G; Yukselen V; Yavasoglu I; Bolaman Z
    Ann Pharmacother; 2003 Apr; 37(4):478-84. PubMed ID: 12659599
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effects of atorvastatin therapy on endothelial function in patients with coronary artery disease.
    Yildiz A; Cakar MA; Baskurt M; Okcun B; Guzelsoy D; Coskun U
    Cardiovasc Ultrasound; 2007 Dec; 5():51. PubMed ID: 18163915
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of alternate-day dosing versus daily dosing of atorvastatin.
    Jafari M; Ebrahimi R; Ahmadi-Kashani M; Balian H; Bashir M
    J Cardiovasc Pharmacol Ther; 2003 Jun; 8(2):123-6. PubMed ID: 12808485
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of atorvastatin treatment on L-arginine cerebrovascular reactivity and flow-mediated dilatation in patients with lacunar infarctions.
    Pretnar-Oblak J; Sabovic M; Sebestjen M; Pogacnik T; Zaletel M
    Stroke; 2006 Oct; 37(10):2540-5. PubMed ID: 16931784
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intensity of lipid lowering with statins and brachial artery vascular endothelium reactivity after acute coronary syndromes (from the BRAVER trial).
    Dupuis J; Tardif JC; Rouleau JL; Ricci J; Arnold M; Lonn E; Roux R; Title LM; Amyot R; Bonafede N; Woo A; Cannon CP
    Am J Cardiol; 2005 Nov; 96(9):1207-13. PubMed ID: 16253583
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE; Feely J; Sigurdsson EL;
    Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of atorvastatin on carotid atherosclerotic plaques: a randomized trial for quantitative tissue characterization of carotid atherosclerotic plaques with integrated backscatter ultrasound.
    Yamada K; Yoshimura S; Kawasaki M; Enomoto Y; Asano T; Minatoguchi S; Iwama T
    Cerebrovasc Dis; 2009; 28(4):417-24. PubMed ID: 19707015
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Beneficial effects of atorvastatin on myocardial regions with initially low vasodilatory capacity at various stages of coronary artery disease.
    Wielepp P; Baller D; Gleichmann U; Pulawski E; Horstkotte D; Burchert W
    Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1371-7. PubMed ID: 16133398
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of atorvastatin on coronary endothelial function in patients with recent myocardial infarction.
    Hosokawa S; Hiasa Y; Tomokane T; Ogura R; Miyajima H; Ohara Y; Ogata T; Yuba K; Suzuki N; Takahashi T; Kishi K; Ohtani R
    Clin Cardiol; 2006 Aug; 29(8):357-62. PubMed ID: 16933577
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study.
    Davidson MH; Rooney MW; Drucker J; Eugene Griffin H; Oosman S; Beckert M;
    Clin Ther; 2009 Dec; 31(12):2824-38. PubMed ID: 20110022
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of intensive versus moderate lipid lowering on endothelial function and vascular responsiveness to angiotensin II in stable coronary artery disease.
    van der Harst P; Wagenaar LJ; Buikema H; Voors AA; Plokker HW; Morshuis WJ; Six AJ; Boonstra PW; Nickenig G; Wassmann S; van Veldhuisen DJ; van Gilst WH
    Am J Cardiol; 2005 Nov; 96(10):1361-4. PubMed ID: 16275178
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Short-term effect of atorvastatin on ischaemic threshold in hypercholesterolaemic patients with stable ischaemic heart disease.
    Claeys MJ; Cosyns B; Hoffer E; Carlier M; Missault L; Cools F; De Meester A; Vermeersch P; Gobin E; Dewit B;
    Acta Cardiol; 2004 Jun; 59(3):269-74. PubMed ID: 15255458
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Determinants of arterial wall remodeling during lipid-lowering therapy: serial intravascular ultrasound observations from the Reversal of Atherosclerosis with Aggressive Lipid Lowering Therapy (REVERSAL) trial.
    Schoenhagen P; Tuzcu EM; Apperson-Hansen C; Wang C; Wolski K; Lin S; Sipahi I; Nicholls SJ; Magyar WA; Loyd A; Churchill T; Crowe T; Nissen SE
    Circulation; 2006 Jun; 113(24):2826-34. PubMed ID: 16769916
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A placebo-controlled trial examining atorvastatin in dyslipidemic patients undergoing CAPD.
    Harris KP; Wheeler DC; Chong CC;
    Kidney Int; 2002 Apr; 61(4):1469-74. PubMed ID: 11918754
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial.
    Bots ML; Visseren FL; Evans GW; Riley WA; Revkin JH; Tegeler CH; Shear CL; Duggan WT; Vicari RM; Grobbee DE; Kastelein JJ;
    Lancet; 2007 Jul; 370(9582):153-160. PubMed ID: 17630038
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of atorvastatin 5 and 20 mg/d for reducing F-18 fluorodeoxyglucose uptake in atherosclerotic plaques on positron emission tomography/computed tomography: a randomized, investigator-blinded, open-label, 6-month study in Japanese adults scheduled for percutaneous coronary intervention.
    Ishii H; Nishio M; Takahashi H; Aoyama T; Tanaka M; Toriyama T; Tamaki T; Yoshikawa D; Hayashi M; Amano T; Matsubara T; Murohara T
    Clin Ther; 2010 Dec; 32(14):2337-47. PubMed ID: 21353104
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of statins (atorvastatin) on serum lipoprotein levels in patients with primary hyperlipidemia and coronary heart disease.
    Jurukovska-Nospal M; Arsova V; Levchanska J; Sidovska-Ivanovska B
    Prilozi; 2007 Dec; 28(2):137-48. PubMed ID: 18356785
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of atorvastatin on type 2 diabetic dyslipidemia.
    Save V; Patil N; Moulik N; Rajadhyaksha G
    J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):262-70. PubMed ID: 17220473
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Usefulness of follow-up low-density lipoprotein cholesterol level as an independent predictor of changes of coronary atherosclerotic plaque size as determined by intravascular ultrasound analysis after statin (atorvastatin or simvastatin) therapy.
    Hong MK; Lee CW; Kim YH; Park DW; Lee SW; Park CB; Jang JS; Han KH; Cheong SS; Kim JJ; Park SW; Park SJ
    Am J Cardiol; 2006 Oct; 98(7):866-70. PubMed ID: 16996864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.